| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-12 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-12 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.28 | 0.0001 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.26 | 5e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.25 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.25 | 0.0003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.25 | 0.001 |